Physician

Robert S. Leverton, M.D.

According to 2025 Medicare claims, Robert Leverton, M.D. (NPI: 1316164783) practices cardiology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is ROBERT S. LEVERTON, M.D., P.A. (NPI: 1588746309; TIN: 752069647) and primary practice location at 79606-5258. Leverton is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974), participating under the MSSP model.

Leverton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,271 traditional Medicare patients, billed 3,818 HCPCS/CPT codes, and received $238,999 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 5,470 prescription claims across 778 beneficiaries totaling $748,612 in drug costs, led by Eliquis (Apixaban). DME data shows 196 claims. Open Payments data shows 6 records totaling $194. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $413,028 to $238,999. In contrast, Part D prescription costs have moved sharply higher in recent years, from $201,947 to $748,612. For DME billing, this smaller-volume category moved sharply higher in recent years, from $13,471 to $8,453.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,548	5,517	$413,028
2016	1,492	5,611	$421,152
2017	1,518	6,305	$436,334
2018	1,574	6,309	$446,237
2019	1,652	6,232	$455,643
2020	1,540	5,955	$369,758
2021	1,433	5,302	$364,490
2022	1,329	4,750	$333,097
2023	1,322	4,335	$308,511
2024	1,271	3,818	$238,999

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	656	4,944	$201,947
2016	667	4,965	$216,267
2017	635	4,836	$241,262
2018	680	4,636	$263,482
2019	694	4,646	$368,588
2020	708	4,695	$474,704
2021	706	4,836	$614,353
2022	729	5,089	$691,355
2023	771	5,219	$775,593
2024	778	5,470	$748,612

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	319	$18,106
2016	N/R	38	$2,027
2017	N/R	32	$1,063
2018	N/R	11	$192
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	117	$9,042
2022	N/R	183	$13,156
2023	N/R	187	$14,528
2024	N/R	196	$16,524

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	123	126	$160
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	910	1,465	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	240	274	$48
93280	Programming of dual lead pacemaker system	147	267	$46
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	955	1,059	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	427	16,659	$311,008
Xarelto	Rivaroxaban	244	10,492	$193,629
Entresto	Sacubitril/Valsartan	169	6,780	$143,110
Brilinta	Ticagrelor	30	1,305	$17,303
Repatha Sureclick	Evolocumab	20	620	$11,895

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1250	Injection, dobutamine hydrochloride, per 250 mg	N	N/R	53	$8,095
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	53	$4,432
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$2,463
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	53	$1,147
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$388

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$194	Recor Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert S. Leverton, M.D.?

Tedicare shows public-source Medicare data for Robert S. Leverton, M.D. (NPI 1316164783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert S. Leverton, M.D. have ACO affiliation data?

Robert S. Leverton, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974).

What billing organization is linked to Robert S. Leverton, M.D.?

Robert S. Leverton, M.D. is linked to ROBERT S. LEVERTON, M.D., P.A. (billing NPI 1588746309) in the available physician profile data.

Does Robert S. Leverton, M.D. have Open Payments data?

Robert S. Leverton, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.